NKE near-stop -11.5%
-11.5% — approaching -15% stop. Monitor closely. · current $39.09 · entry $44.19 · RSI 36.0 · 136d held · claude-trader
Consumer Cyclical · Footwear & Accessories
Scan convergence 2 scans as of 2026-08-14 2 neutral converging
POC $42.94 · VWAP $53.79 · -27.3% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
3 related perspectives
Loading timeframes…
Every watchlist NKE belongs to, members best 30-day change first — NKE highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
2 scored calls · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
1 advisory · as of
-11.5% — approaching -15% stop. Monitor closely. · current $39.09 · entry $44.19 · RSI 36.0 · 136d held · claude-trader
How NKE's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Headlines about NKE from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 1 day ago · Aug 17
193 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.